| Title |
Author(s) |
Journal |
Issue Date |
Type |
|
Mosquito vectors of disease: spatial biodiversity, drivers of change, and risk; final report
|
Versteirt, V.; De Clercq, E.; Dekoninck, W.; Damiens, D.; Ayrinhac, A.; Jacobs, F.; Van Bortel, W.
|
|
2009
|
Document
|
|
Report of the thirteenth WHOPES working group meeting: WHO/HQ, Geneva, 28-30 July 2009: review of Olyset® LN, Dawaplus® 2.0 LN, Tianjin Yorkool® LN
|
Bhatt, R.; Boakye, D.; Chandre, F.; Coosemans, M.; Corbel, V.; Gimnig, J.; Nkuni, J.; Lines, J.; Pigeon, O.; Rowland, M.; Velayudhan, R.; Yadav, R.; Zaim, M.
|
|
2009
|
Document
|
|
Report of the twelfth WHOPES working group meeting: WHO/HQ, Geneva, 8-11 December 2008: review of Bioflash® GR, Permanet® 2.0, Permanet® 3.0, Permanet® 2.5, Lambda-Cyhalothrin LN
|
Van Bortel, W.; Chandre, F.; Coosemans, M.; Corbel, V.; Gimnig, J.; Hougard, J. M.; Ichimori, K.; Jambulingam, P.; Ladonni, H.; Mulla, M. S.; Nkuni, J.; Pigeon, O.; Rowland, M.; Zaim, M.
|
|
2009
|
Document
|
|
Recommendations of the informal consultation on issues for clinical product development for human African trypanosomiasis; Geneva, Switzerland, 9-10 September 2004
|
Unknown author |
|
2007
|
Document
|
|
Recommandations de la consultation informelle surles questions relatives au développement de produits cliniques pour la trypanosomiase humaine africaine; Genève, Suisse, 9-10 septembre 2004
|
Unknown author |
|
2007
|
Document
|